Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy

The use of adeno-associated virus (AAV) as a gene therapy vector has been approved recently for clinical use and has demonstrated efficacy in a growing number of clinical trials. However, the safety of AAV as a vector has been challenged by a single study that documented hepatocellular carcinoma (HC...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Invest
Hoofdauteurs: Chandler, Randy J., LaFave, Matthew C., Varshney, Gaurav K., Trivedi, Niraj S., Carrillo-Carrasco, Nuria, Senac, Julien S., Wu, Weiwei, Hoffmann, Victoria, Elkahloun, Abdel G., Burgess, Shawn M., Venditti, Charles P.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Clinical Investigation 2015
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4319425/
https://ncbi.nlm.nih.gov/pubmed/25607839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI79213
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items